Antibiotics, Antineoplastic < Antibodies < Antibodies, Anti-Idiotypic

Facettes : Author.f AffPays.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 41.
[0-20] [0 - 20][0 - 41][20-40]

Ident.	Authors (with country if any)	Title
000915 (2018)	Xuanwei Zhang [République populaire de Chine] ; Gabriele Niedermann [Allemagne]	Abscopal Effects With Hypofractionated Schedules Extending Into the Effector Phase of the Tumor-Specific T-Cell Response.
000B66 (2017)	Jun Ohata [États-Unis] ; Zachary T. Ball [États-Unis]	A Hexa-rhodium Metallopeptide Catalyst for Site-Specific Functionalization of Natural Antibodies.
000E78 (2016)	G. Lombardi [Italie] ; S. Perego [Italie] ; V. Sansoni [Italie] ; M. Diani [Italie] ; G. Banfi [Italie] ; G. Altomare [Italie]	Anti-adalimumab antibodies in psoriasis: lack of clinical utility and laboratory evidence.
001073 (2017)	Tatsuro Okano [Japon] ; Sora Takeuchi [Japon] ; Yoshinao Soma [Japon] ; Koya Suzuki [Japon] ; Sachiko Tsukita [Japon] ; Akihiro Ishizu [Japon] ; Kazuo Suzuki [Japon] ; Tamihiro Kawakami [Japon]	Presence of anti-phosphatidylserine-prothrombin complex antibodies and anti-moesin antibodies in patients with polyarteritis nodosa.
001520 (2015)	Joana D'Arc Campeiro [Brésil] ; Izabella P. Neshich [Brésil] ; Osvaldo A. Sant'Anna [Brésil] ; Robson Lopes [Brésil] ; Danielle Ianzer [Brésil] ; Marina T. Assakura [Brésil] ; Goran Neshich [Brésil] ; Mirian A F. Hayashi [Brésil]	Identification of snake bradykinin-potentiating peptides (BPPs)-simile sequences in rat brain--Potential BPP-like precursor protein?
001779 (2015)	Sung Mook Lim [Corée du Sud] ; Ha Na Eom ; Hai Hua Jiang ; Minji Sohn ; Kang Choon Lee	Evaluation of PEGylated exendin-4 released from poly (lactic-co-glycolic acid) microspheres for antidiabetic therapy.
001C15 (2014)	Vasudevanpillai Biju [Japon]	Chemical modifications and bioconjugate reactions of nanomaterials for sensing, imaging, drug delivery and therapy.
001D98 (2014)	Sandra Garcês [Portugal] ; Marília Antunes ; Elizabeth Benito-Garcia ; José Canas Da Silva ; Lucien Aarden ; Jocelyne Demengeot	A preliminary algorithm introducing immunogenicity assessment in the management of patients with RA receiving tumour necrosis factor inhibitor therapies.
001E16 (2013)	Susann Katrina Julie Ludwig [Pays-Bas] ; Nathalie Gabriëlle Esther Smits ; Francesca Tiziana Cannizzo ; Michel Wilhelmus Franciscus Nielen	Potential of treatment-specific protein biomarker profiles for detection of hormone abuse in cattle.
001E92 (2013)	Salvador Eugenio C. Caoili [Philippines]	Antidotes, antibody-mediated immunity and the future of pharmaceutical product development.
001F13 (2012)	Timothy W. Phares [États-Unis] ; Stephen A. Stohlman ; David R. Hinton ; Cornelia C. Bergmann	Enhanced CD8 T-cell anti-viral function and clinical disease in B7-H1-deficient mice requires CD4 T cells during encephalomyelitis.
002105 (2012)	Lutz Heinemann [Allemagne]	Biosimilar insulins.
002187 (2012)	María Cristina Ortega [Espagne] ; Olivier Cases ; Paloma Merchán ; Renata Kozyraki ; Diego Clemente ; Fernando De Castro	Megalin mediates the influence of sonic hedgehog on oligodendrocyte precursor cell migration and proliferation during development.
002461 (2011)	Weiye Chen [République populaire de Chine] ; Wenyan Cao ; Huijun Zhao ; Qianqian Hu ; Linmao Qu ; Sen Hu ; Jinying Ge ; Zhiyuan Wen ; Xijun Wang ; Haobo Li ; Kehe Huang ; Zhigao Bu	Establishment of a stable CHO cell line with high level expression of recombinant porcine IFN-β.
002907 (2010)	Su Jin Hwang [Corée du Sud] ; Ji Hyung Kim ; Hye Young Kim ; Sanghee Kim ; Doo Hyun Chung	FTY720, a sphingosine 1-phosphate receptor modulator, inhibits CD1d-restricted NKT cells by suppressing cytokine production but not migration.
002B04 (2009)	Antonio Bertolotto [Italie]	Implications of neutralising antibodies on therapeutic efficacy.
002B38 (2009)	M. Moore [Royaume-Uni] ; A. Meager ; M. Wadhwa ; C. Burns	Measurement of neutralising antibodies to type I interferons by gene expression assays specific for type 1 interferon-inducible 6-16 mRNA.
002B45 (2009)	Stephen T. Holgate [Royaume-Uni]	Novel targets of therapy in asthma.
002C96 (2008)	Shihua Wang [République populaire de Chine] ; Cengjie Zheng ; Ying Liu ; Huirong Zheng ; Zonghua Wang	Construction of multiform scFv antibodies using linker peptide.
002D43 (2008)	Wei-Gang Hu [Canada] ; Les P. Nagata	Antibody gene-based prophylaxis and therapy for biodefence.
002E24 (2008)	Luz Cristal Glangchai [États-Unis] ; Mary Caldorera-Moore ; Li Shi ; Krishnendu Roy	Nanoimprint lithography based fabrication of shape-specific, enzymatically-triggered smart nanoparticles.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/BiopestPeptidV1/Data/Main/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/MedMesh.i -k "Antibodies" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/MedMesh.i  \
                -Sk "Antibodies" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    BiopestPeptidV1
   |flux=    Main
   |étape=   Curation
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Antibodies
}}

---

This area was generated with Dilib version V0.6.38. Data generation: Thu Nov 19 19:22:35 2020. Site generation: Thu Nov 19 19:33:26 2020